Further studies on estimating the effect of gene-gene and gene-environment interactions may eventually lead to a better and more comprehensive understanding of the association between the NAT1 and NAT2 genotype and CRC and CRA risk. The gene discussed is NAT2; the disease is colorectal carcinoma.